Merck‘s new HIV treatment recommended by FDA panel for approval: The advisory panel voted unanimously to recommend marketing approval for the twice-a-day pill, known generically as raltegravir, the first in a novel class of AIDS treatments to go before regulators…more
Pfizer‘s spin on Lipitor-switchers called into question: Why did more people die after switching from Lipitor to generic Zocor? This kind of “study” is great for headlines; maybe not for responsible clinical decision-making…more and more
Lots of prescriptions for bi-polar kids: Sales for children of antipsychotic medicines made by Johnson & Johnson, AstraZeneca Plc and Pfizer Inc. have exploded, fueled by a 40-fold increase over nine years in the number of children diagnosed with bipolar disorder…more
Cephalon gets orphan designation for its oncology drug Treanda (leukemia).
The battle continues to rage on stents – drug coated stents worse after acute heart attacks? Meanwhile, Boston Scientific reports positive long-term safety results on its Taxus stents.
Anti-depressants and youth suicides – fewer prescriptions, more deaths?
The Medical Marketing and Media annual pharma sales/marketing salary survey report (2007) – free download here.
Leave a Reply